ST6GALNAC2P1

Across TCGA pan-cancer cohorts, ST6GALNAC2P1 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated ST6GALNAC2P1 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher ST6GALNAC2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ST6GALNAC2P1 expression acts as an unfavorable survival marker.

SKCM, DLBC, and KICH are the cancer types where ST6GALNAC2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.174	0.877	<.001	60	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	46	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
BLCA	OS	Tertile	IV	0.051	0.600	<.001	36	view →
CESC	DFS	Tertile	III,IV	0.173	0.634	.006	36	view →
STAD	DFS	Tertile	All	0.453	0.735	.003	27	view →
TGCT	DFS	Tertile	All	0.495	0.843	.011	18	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

ST6GALNAC2P1–SKCM (OS)

Open the SKCM breakdown →